Carregando…
Electra Therapeutics, Inc.
Grandes gestores que reportaram esta ação no 13F mais recente.
Nenhum dos investidores acompanhados reportou posição em ETRA.
Empresas de tamanho parecido em Healthcare, para comparar. As colunas são as mesmas de cima, na mesma ordem.
| Ação | Preço | P/L | P/VP | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| DNAGinkgo Bioworks Holdings, Inc. | $10.46 | — | 1.6x | — | -59.94% | $704.38M |
| VSTMVerastem, Inc. | $7.77 | — | 8.3x | — | -471.16% | $703.68M |
| FTHFaeth Therapeutics, Inc. | $27.77 | — | 4.1x | — | -195.26% | $717.59M |
| IMMPIMMUTEP Ltd | $4.88 |
Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.
Descrição da empresa fornecida pelo Yahoo Finance. A descrição é publicada pela fonte apenas em inglês.
| — |
| 16.4x |
| — |
| -77.31% |
| $719.18M |
| COLLCollegium Pharmaceutical Inc | $22.63 | 17.8x | 2.4x | — | 17.61% | $701.51M |
| SOPHSOPHiA GENETICS SA | $8.49 | — | 8.7x | — | -101.22% | $722.74M |